Journalists covering the recent announcement by Pathway Genomics that it will sell health-related genetic marker tests to consumers-and the subsequent decision by Walgreens to postpone sales of the kits pending clarification of their legal status-are invited to interview Berman Institute experts Joan Scott or Gail Javitt. The drugstore chain recently announced that plans to sell the so-called "spit kit" are now on hold after the Food and Drug Administration (FDA) sent a letter to Pathway questioning whether the company had received FDA authorization to market the device... 
More...
More...